Form 4 Tracker
Mineralys Therapeutics, Inc.
MLYS

31 insider filings · Latest: Jun 30, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 30, 2026Jun 30 10:41 PMJon CongletonDirector, Chief Executive Officer
Sale
75,000$26.14$2.0M614,321(D)

View →

Jun 26, 2026Jun 30 10:41 PMEric WarrenChief Commercial Officer
Sale
104,124$25.90$2.7M38,400(D)

View →

Jun 30, 2026Jun 30 8:20 PMCongleton Jon
Proposed Sale
75,000$26.14$2.0M

View →

Jun 26, 2026Jun 29 1:05 PMWarren Eric
Proposed Sale
104,124$25.90$2.7M

View →

Jun 17, 2026Jun 18 1:18 AMDavid Malcom RodmanChief Medical Officer
Sale
4,584$25.00$114.6K57,095(D)

View →

Jun 15, 2026Jun 18 1:18 AMDavid Malcom RodmanChief Medical Officer
Sale
9,890$23.81$235.5K57,095(D)

View →

Jun 17, 2026Jun 18 1:18 AMDaphne KarydasDirector
Sale
3,000$25.00$75.0K6,200(D)

View →

Jun 17, 2026Jun 17 8:20 PMRodman David Malcom
Proposed Sale
4,584$25.00$114.6K

View →

Jun 17, 2026Jun 17 8:15 PMKarydas Daphne
Proposed Sale
3,000$25.00$75.0K

View →

Jun 15, 2026Jun 15 8:58 PMRodman David Malcom
Proposed Sale
9,890$23.81$235.5K

View →

Jun 12, 2026Jun 12 10:04 PMDavid Malcom RodmanChief Medical Officer
Sale
6,349$23.93$151.9K63,443(D)

View →

Jun 10, 2026Jun 12 10:04 PMDavid Malcom RodmanChief Medical Officer
Sale
2,170$25.00$54.3K63,443(D)

View →

Jun 12, 2026Jun 12 8:17 PMRodman David Malcom
Proposed Sale
6,349$23.93$151.9K

View →

Jun 10, 2026Jun 10 8:11 PMRodman David Malcom
Proposed Sale
2,170$25.00$54.3K

View →

May 18, 2026May 19 11:15 PMDavid Malcom RodmanChief Medical Officer
Sale
417$27.55$11.5K63,443(D)

View →

May 18, 2026May 18 8:10 PMRodman David Malcom
Proposed Sale
417$27.55$11.5K

View →

May 13, 2026May 14 1:42 AMDavid Malcom RodmanChief Medical Officer
Sale
14,056$28.58$401.8K63,443(D)

View →

May 12, 2026May 14 1:42 AMDavid Malcom RodmanChief Medical Officer
Sale
6,348$29.36$186.3K69,792(D)

View →

May 11, 2026May 14 1:42 AMDavid Malcom RodmanChief Medical Officer
Sale
2,171$29.71$64.5K69,792(D)

View →

May 13, 2026May 13 8:11 PMRodman David Malcom
Proposed Sale
14,056$28.58$401.8K

View →

Page 1 of 5

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 19, 2026Feb 21 12:47 AMGlenn SblendorioDirector
Grant/Award
8,300$28.068,300(D)

View →

Feb 19, 2026Feb 21 12:47 AMAlexander M GoldDirector
Grant/Award
8,300$28.068,300(D)

View →

Feb 19, 2026Feb 21 12:47 AMDaphne KarydasDirector
Grant/Award
8,300$28.068,300(D)

View →

Feb 19, 2026Feb 21 12:47 AMBrian Taylor SlingsbyDirector, 10% Owner
Other (J)
8,300$28.060(D)

View →

Feb 19, 2026Feb 21 12:47 AMBrian Taylor SlingsbyDirector, 10% Owner
Other (J)
8,300$28.068,300(I)

View →

Feb 19, 2026Feb 21 12:47 AMBrian Taylor SlingsbyDirector, 10% Owner
Grant/Award
8,300$28.068,300(D)

View →

Feb 19, 2026Feb 21 12:47 AMSrinivas AkkarajuDirector, 10% Owner
Grant/Award
8,300$28.068,300(D)

View →

Feb 19, 2026Feb 21 12:47 AMDerek DiroccoDirector
Grant/Award
8,300$28.068,300(D)

View →

Feb 19, 2026Feb 21 12:46 AMDavid Malcom RodmanChief Medical Officer
Grant/Award
51,300$28.0651,300(D)

View →

Feb 19, 2026Feb 21 12:46 AMAdam Scott LevyCFO and Secretary
Grant/Award
53,300$28.0653,300(D)

View →

Feb 17, 2026Feb 17 11:56 PMDavid Malcom RodmanChief Medical Officer
Option Exercise
417$15.445,417(D)

View →

Feb 13, 2026Feb 14 12:25 AMDavid Malcom RodmanChief Medical Officer
Option Exercise
7,707$14.25100,001(D)

View →

Feb 12, 2026Feb 14 12:25 AMDavid Malcom RodmanChief Medical Officer
Option Exercise
6,349$1.0831,743(D)

View →

Feb 9, 2026Feb 11 11:58 PMDavid Malcom RodmanChief Medical Officer
Option Exercise
2,171$16.0026,047(D)

View →

Jan 20, 2026Jan 21 1:33 AMDavid Malcom RodmanChief Medical Officer
Option Exercise
416$15.445,834(D)

View →

← Previous

Page 2 of 2